Gut microbiome and digestive system concept

Microbiome-based therapies could help countless people this year. (© sdecoret - stock.adobe.com

In a nutshell

  • A specific probiotic strain (Bifidobacterium animalis subsp. Lactis A6) significantly improved both depression and constipation symptoms in people who had both conditions
  • The treatment works by rebalancing how the body processes tryptophan, increasing mood-boosting serotonin while decreasing problematic kynurenine
  • People with depression alone didn’t benefit, showing that the gut-brain connection becomes crucial when digestive issues are also present

BEIJING — Got the blues and can’t go? You’re not alone, and science may have found a surprising solution. Researchers from China Agricultural University discovered that a specific gut bacteria strain can tackle both depression and constipation together, offering hope for millions dealing with this frustrating double burden.

The probiotic, known as Bifidobacterium animalis subsp. Lactis A6, significantly improved mood and bowel movements in people suffering from both conditions during an eight-week clinical trial. It works by fixing the body’s production of serotonin, the brain chemical that controls both happiness and healthy digestion.

According to national health data, depression affects about 21 million American adults each year. Prior studies also suggest that constipation is significantly more common in people with depression, highlighting how closely these two conditions can be linked through what scientists call the gut-brain axis.

How Scientists Tested the Gut-Brain Connection

Researchers divided study participants with depression into four groups during their eight-week trial. Some had constipation, others didn’t. Half received the probiotic, half got a placebo containing maltodextrin.

Only one group saw major improvements: people with both depression and constipation who took the probiotic. Their depression scores on the Hamilton Depression Rating Scale dropped from an average of 12.77 to 9.48, a meaningful change that translates to better daily functioning. Their constipation symptoms, measured by the Patient Assessment of Constipation-Symptom scale, also improved significantly (scores dropped from 1.13 to 0.97).

People with depression alone didn’t benefit, revealing that the gut-digestion connection becomes crucial when both issues are present.

Woman in pain, stomach cramps, feeling sick
Photo by Sora Shimazaki from Pexels

The Serotonin Factory Gets Fixed

The probiotic essentially repaired the body’s serotonin manufacturing process. Our bodies use an amino acid called tryptophan as raw material to make either serotonin (good for mood and digestion) or kynurenine (problematic when levels get too high).

In people taking the probiotic, blood and stool tests showed higher serotonin levels and lower kynurenine levels. The treatment also boosted beneficial bacteria strains including Lactobacillus paracaseiLactobacillus plantarum, and Bifidobacterium animalis.

Animal studies using rats fed a low-fiber diet confirmed these results. Rats developed both depression-like behaviors and constipation, but the probiotic reversed both problems. The treatment increased production of an enzyme called tryptophan hydroxylase 1 that makes serotonin, while decreasing production of indoleamine 2,3-dioxigenase 1 that creates kynurenine.

Why This Matters for Treatment

Current antidepressants target brain chemistry directly, but these results point toward treating mood through the digestive system. For people dealing with both mental health struggles and digestive issues, the gut might hold the key to feeling better overall.

Just remember, in this study, the specific bacterial strain matters. The same results do not apply to any random probiotic from the drugstore shelf. The researchers used Bifidobacterium animalis subsp. Lactis A6, originally isolated from a centenarian’s stool sample in China, showing how particular strains can have unique health benefits.

However, the study included only Chinese participants and didn’t account for dietary differences that affect gut bacteria. Larger, more diverse studies are needed before doctors can confidently recommend this approach for American patients.

Rather than treating depression and constipation as separate problems, this research supports precision medicine — tailoring treatments based on a person’s specific combination of symptoms. For some people, the path to better mental health might run straight through their stomach.


Paper Summary

Methodology

Researchers conducted an eight-week, double-blind, placebo-controlled clinical trial at China Agricultural University. They randomly assigned participants with depression into four groups: those with constipation receiving either the probiotic Bifidobacterium animalis subsp. Lactis A6 (3×10¹⁰ CFU/day) or placebo, and those without constipation receiving either treatment or placebo. Participants were evaluated using standard depression and constipation scoring systems at the beginning and end of the trial. The team also conducted animal studies using rats fed low-fiber diets to develop both depression-like behaviors and constipation, then treated them with the same probiotic strain.

Results

The probiotic significantly improved both depression scores (from 12.77 to 9.48) and constipation symptoms in participants who had both conditions, but showed no benefit for those with depression alone. Blood and stool analysis revealed increased serotonin levels and decreased kynurenine levels in the treatment group. Gut bacteria composition changed favorably, with increases in beneficial Lactobacillus and Bifidobacterium strains. Animal studies confirmed these findings and revealed that the probiotic works by increasing tryptophan hydroxylase 1 (which makes serotonin) while decreasing indoleamine 2,3-dioxigenase 1 (which makes kynurenine).

Limitations

The study included only Chinese participants, limiting generalizability to other populations. Researchers didn’t control for dietary factors that could influence gut bacteria composition. The sample size was relatively small, and larger studies are needed to confirm sex differences in treatment outcomes. The causes of comorbid depression and constipation are diverse, requiring more targeted experimental designs for different patient subgroups.

Funding and Disclosures

This research was supported by the National Key R&D Program of China, the 111 Project of the Education Ministry of China, and the National Center of Technology Innovation for Dairy. The authors declared no conflicts of interest.

Publication Information

Wang, J., Ren, Y., Chen, J., et al. “Bifidobacterium animalis subsp. Lactis A6 alleviates comorbid constipation and depression by rebalancing tryptophan metabolism” is published in Science Bulletin (2025). DOI: 10.1016/j.scib.2025.04.042

About StudyFinds Analysis

Called "brilliant," "fantastic," and "spot on" by scientists and researchers, our acclaimed StudyFinds Analysis articles are created using an exclusive AI-based model with complete human oversight by the StudyFinds Editorial Team. For these articles, we use an unparalleled LLM process across multiple systems to analyze entire journal papers, extract data, and create accurate, accessible content. Our writing and editing team proofreads and polishes each and every article before publishing. With recent studies showing that artificial intelligence can interpret scientific research as well as (or even better) than field experts and specialists, StudyFinds was among the earliest to adopt and test this technology before approving its widespread use on our site. We stand by our practice and continuously update our processes to ensure the very highest level of accuracy. Read our AI Policy (link below) for more information.

Our Editorial Process

StudyFinds publishes digestible, agenda-free, transparent research summaries that are intended to inform the reader as well as stir civil, educated debate. We do not agree nor disagree with any of the studies we post, rather, we encourage our readers to debate the veracity of the findings themselves. All articles published on StudyFinds are vetted by our editors prior to publication and include links back to the source or corresponding journal article, if possible.

Our Editorial Team

Steve Fink

Editor-in-Chief

John Anderer

Associate Editor

Leave a Reply

1 Comment

  1. Lynda Raisig says:

    Where can you find this probiotic? Is it on the market yet.